Author:
Cruciani Mario,Mengoli Carlo,Serpelloni Giovanni,Parisi Saverio G
Reference20 articles.
1. Benson C Ribaudo H Zheng E No association of Abacavir use with risk of myocardial infarction or severe cardiovascular disease events; results from ACTG A5001. Abst. 721
2. Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects;Brothers;Journal of the Acquired Immune Deficiency Syndrome.
3. A Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients.;Bucher;AIDS,2003
4. Simplification with ABC-based triple nucleoside therapy vs continued PI-based ART in HIV-1-infected patients with undetectable plasma HIV-1 RNA (CNA300017);Clumeck;AIDS,2001
5. Class of antiretroviral drugs and the risk of myocardial infarction;New England Journal of Medicine,2007